GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (LTS:0G5I) » Definitions » Total Equity

Prolight Diagnostics AB (LTS:0G5I) Total Equity : kr128.29 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Prolight Diagnostics AB Total Equity?

Prolight Diagnostics AB's total equity for the quarter that ended in Dec. 2024 was kr128.29 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Prolight Diagnostics AB Total Equity Historical Data

The historical data trend for Prolight Diagnostics AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB Total Equity Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only 153.17 146.31 205.41 132.99 128.29

Prolight Diagnostics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.99 124.32 122.28 114.03 128.29

Prolight Diagnostics AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Prolight Diagnostics AB's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=166.331-38.047
=128.28

Prolight Diagnostics AB's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=166.331-38.047
=128.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prolight Diagnostics AB Total Equity Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Prolight Diagnostics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (LTS:0G5I) » Definitions » Total Equity
Comparable Companies
XSAT:BPCINS OSTO:ADDV A OSTO:ORTI A OSTO:IZAFE B XSAT:ODIN OSTO:S2M XSAT:AUDNTS XSAT:MEDIMI OSTO:STIL ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM BAX
Traded in Other Exchanges
PRLD:Sweden
Address
Gasverksgatan 3A, Lund, SWE, 222 29
Website
https://www.prolightdx.com
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.

Prolight Diagnostics AB Headlines

No Headlines